Latest Publication

Convergence_in_Healthcare_Market.jpg

Convergence in Healthcare Market Size, Share & Trends Analysis Report, Product Type (Diagnostic Imaging Systems, Monitoring Devices, Digital Therapeutics, Others), By Application (Cardiology, Oncology, Neurology, Orthopedics, Others), By End User (Hospitals & Clinics, Diagnostic Centers, Home Care Settings, Others), By Region, Forecasts, 2024-2031

Convergence in Healthcare Market Size is valued at USD 126.2 Bn in 2023 and is predicted to reach USD 304.5 Bn by the year 2031 at a 11.78% CAGR during the forecast period for 2024-2031. Convergence in healthcare refers to the integration of multi...

View Sample PDF

Bird_Flu_Market.JPG

Bird Flu Market Size, Share & Trends Analysis Report By Virus Type (H5N1, H7N9, H5N6, H5N8, H10N8, H9N2, Others), By Test Type (PCR Tests, ELISA Tests, Hemagglutination Assays, Virus Isolation Tests, Next Generation Sequencing, Others), By Treatment Type, By Animal Type, By Region, And By Segment Forecasts, 2024-2031

Bird Flu Market Size is valued at USD 1.41 Bn in 2023 and is predicted to reach USD 2.17 Bn by the year 2031 at a 5.82% CAGR during the forecast period for 2024-2031. Bird flu is an infectious type virus that primarily affects birds which can caus...

View Sample PDF

Workout_Supplements_Market.jpg

Workout Supplements Market Size, Share & Trends Analysis Report By Product Type (Powder, Capsule/ Tablet, Drinks, Other Types), By Distribution Channel (Supermarkets & Hypermarkets, E-commerce and Online Stores, Drug stores and Pharmacies, Other Offline stores), By Region, And By Segment Forecasts, 2024-2031

Workout Supplements Market Size is valued at USD 18.17 Bn in 2023 and is predicted to reach USD 35.55 Bn by the year 2031 at a 8.95% CAGR during the forecast period for 2024-2031. The market for workout supplements provides a range of goods to ass...

View Sample PDF

Omics-Based_Clinical_Trials_Market.JPG

Omics-Based Clinical Trials Market Size, Share & Trends Analysis Report By Phase Type (Phase I, Phase II, Phase III, and Phase IV), By Study Design Type (Interventional Studies, Observational Studies, and Expanded Access Studies), By Indication Type (Oncology, Cardiology, Respiratory Diseases, Skin Diseases, CNS Diseases, Immunology, Genetic Diseases, and Others), By Region, And By Segment Forecasts, 2024-2031

Omics-Based Clinical Trials Market Size is valued at USD 29.51 billion in 2023 and is predicted to reach USD 54.42 billion by the year 2031 at a 8.13% CAGR during the forecast period for 2023-2031. Omics-based clinical trials represent a significa...

View Sample PDF

Digital_Therapeutics_Medical_Devices_for_Migraine_Market.JPG

Digital Therapeutics & Medical Devices for Migraine Market Size, Share & Trends Analysis Report By Type (Arm Device, Neck Device, Head/Forehead Device, and Others), By Age Group (Above 18 Years and Above 12 Years), By Mode of Action (Electrical Pulse, Mild Electrical Stimulation, and Deep Muscle Treatment), By Region, And By Segment Forecasts, 2024-2031

Digital Therapeutics & Medical Devices for Migraine Market Size is predicted to witness a 8.6% CAGR during the forecast period for 2024-2031. Digital therapeutics and medical devices for migraines describe interventions that use technology to ...

View Sample PDF

Autoimmune_Polyglandular_Syndrome_Market.jpg

Autoimmune Polyglandular Syndrome Type 1 Market Size, Share & Trends Analysis Report By Diagnosis (Serum Autoimmune Screen, End-organ Function Tests, Blood Tests, Others), Age of Onset (Childhood, Adult, Adolescent), Treatment (Medication, Hormone Replacement Therapy, Others), Dosage Form (Tablet, Capsule, Others), Route of Administration, End-Users, Distribution Channel, By Region, And By Segment Forecasts, 2024-2031

Autoimmune Polyglandular Syndrome Type 1 Market Size is valued at USD 244.1 Mn in 2023 and is predicted to reach USD 389.6 Mn by the year 2031 at a 6.20% CAGR during the forecast period for 2024-2031. Autoimmune Polyglandular Syndrome type 1 is an...

View Sample PDF

Slide2-min64.JPG

DNA/RNA Sample Extraction and Isolation Market Size, Share & Trends Analysis Report By Product (Consumables (Kits (DNA Kits, RNA Kits), Reagents), Instruments), By Technology (Consumable-Based Technology (Silica-Based, Magnetic Particle Technology, Other Technologies), Instrument-Based Technology (Automated Spin Column-Based, Magnetic Bead-Based, Automated Liquid Handling), By Application, By End-User, By Region, And By Segment Forecasts, 2024-2031

DNA/RNA Sample Extraction and Isolation Market Size is valued at USD 2.47 Bn in 2023 and is predicted to reach USD 4.14 Bn by the year 2031 at a 6.80% CAGR during the forecast period for 2024-2031.  The extraction and isolation of DNA/RN...

View Sample PDF

Slide2-min68.JPG

Lithium Iron Phosphate Batteries Market Size, Share & Trends Analysis Report By Design (Cell, Battery Pack), By Voltage (Low (Below 12 V), Medium (12-36 V), High (Above 36 V)), By Capacity (0–16,250 MAH, 16,251–50,000 MAH, 50,001–100,000 MAH, 100,001–540,000 MAH), By Application (Portable, Stationary), By Industry, By Region, And By Segment Forecasts, 2024-2031

Lithium Iron Phosphate Batteries Market Size is valued at USD 17.54 Bn in 2023 and is predicted to reach USD 48.95 Bn by the year 2031 at a 13.85% CAGR during the forecast period for 2024-2031.  Lithium iron phosphate (LFP) battery ...

View Sample PDF

Baculovirus_Expression_System_Market.JPG

Baculovirus Expression System Market Size, Share & Trends Analysis Report By Product Type (Baculovirus, Expression Vector, Reagents, Others), By Application (Therapeutics, Vaccines, Protein Purification, Others), By End User (Biopharmaceutical Companies, Research Institutes, Others), By Region, And By Segment Forecasts, 2024-2031

Baculovirus Expression System Market Size is valued at USD 374.79 Mn in 2023 and is predicted to reach USD 660.97 Mn by the year 2031 at a 7.43% CAGR during the forecast period for 2024-2031.  The baculovirus vector system induces recomb...

View Sample PDF

Slide2-min67.JPG

HIV-Associated Lipodystrophy Treatment Market Size, Share & Trends Analysis Report by Lipodystrophy Type (Lipoatrophy and Lipoaccumulation), by Therapeutic class (Anabolism Modulators, Insulin Resistance Modulators, Mitochondrial Antioxidants (l-carnitine), and Other), by Distribution Channels (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Region, And By Segment Forecasts, 2024-2031

HIV-Associated Lipodystrophy Treatment Market Size is valued at USD 176.82 Mn in 2023 and is predicted to reach USD 239.62 Mn by the year 2031 at a 4.05% CAGR during the forecast period for 2024-2031.  HIV-associated lipodystrophy is an ...

View Sample PDF

Categories